Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients ≥12 Years of Age With Acne Vulgaris
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Long-Term Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients Greater Than or Equal to 12 Years of Age With Acne Vulgaris
J Drugs Dermatol 2023 Aug 01;22(8)810-816, LF Eichenfield, AA Hebert, LS Gold, M Cartwright, L Moro, J Han, N Squittieri, A MazzettiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.